Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Cancer Immunology Research|June 22, 2014
Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugatesGijs G Zom, Selina Khan, Cedrik M Britten, et al.
Cancer Research|November 5, 2002
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cellsSander Zwaveling, Michel P M Vierboom, Sandra C Ferreira Mota, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytesNadine van Montfoort, Judith M H de Jong, Danita H Schuurhuis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidasesSabrina Urban, Kathrin Textoris-Taube, Barbara Reimann, et al.
Transplantation|January 2, 2004
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cellsDave L Roelen, Danita H Schuurhuis, Daniëlle E M van den Boogaardt, et al.
Oncoimmunology|September 14, 2020
Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancerBrett J Hos, Marcel G M Camps, Jitske van den Bulk, et al.
International Journal of Cancer|April 29, 2006
CD8 T-cell recognition of human 5T4 oncofetal antigenLucy J C Smyth, Eyad Elkord, Taher E I Taher, et al.
Molecular Immunology|November 28, 2017
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responsesSara M Mangsbo, Erika A K Fletcher, Wendy W C van Maren, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Cancer Immunology Research|June 22, 2014
Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugatesGijs G Zom, Selina Khan, Cedrik M Britten, et al.
Cancer Research|November 5, 2002
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cellsSander Zwaveling, Michel P M Vierboom, Sandra C Ferreira Mota, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytesNadine van Montfoort, Judith M H de Jong, Danita H Schuurhuis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2012
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidasesSabrina Urban, Kathrin Textoris-Taube, Barbara Reimann, et al.
Transplantation|January 2, 2004
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cellsDave L Roelen, Danita H Schuurhuis, Daniëlle E M van den Boogaardt, et al.
Oncoimmunology|September 14, 2020
Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancerBrett J Hos, Marcel G M Camps, Jitske van den Bulk, et al.
International Journal of Cancer|April 29, 2006
CD8 T-cell recognition of human 5T4 oncofetal antigenLucy J C Smyth, Eyad Elkord, Taher E I Taher, et al.
Molecular Immunology|November 28, 2017
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responsesSara M Mangsbo, Erika A K Fletcher, Wendy W C van Maren, et al.
The Journal of Biological Chemistry|April 28, 2007
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cellsSelina Khan, Martijn S Bijker, Jimmy J Weterings, et al.
International Journal of Cancer|September 28, 2018
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelHeng Sheng Sow, Hreinn Benonisson, Cor Breukel, et al.
Pageof 16